• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Scopus
  4. Continued symptom and quality of life improvement with favorable safety shown with long-term avapritinib in indolent systemic mastocytosis
 
  • Details
  • Full
Options
2025
Journal Article
Title

Continued symptom and quality of life improvement with favorable safety shown with long-term avapritinib in indolent systemic mastocytosis

Author(s)
Castells, Mariana Concepcion
Brigham and Women's Hospital
Akin, Cem
University of Michigan, Ann Arbor
Hartmann, Karin
Universitätsspital Basel
Broesby-Olsen, Sigurd
Odense Universitetshospital
George, Tracy Irene
ARUP Laboratories
Powell, Dakota
Blueprint Medicines Corporation
Bidollari, Ilda
Blueprint Medicines Corporation
Lin, Huimin
Blueprint Medicines Corporation
Lampson, Benjamin
Blueprint Medicines Corporation
Doyle, Ashley
Blueprint Medicines Corporation
Siebenhaar, Frank
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Sabato, Vito
Universitair Ziekenhuis Antwerpen
Journal
The journal of allergy and clinical immunology. In practice  
Open Access
DOI
10.1016/j.jaip.2025.05.026
Additional link
Full text
Language
English
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024